Funding for this research was provided by:
Cancer Research UK
Sydney West Radiation Oncology Network Royal Australian and New Zealand College of Radiologists
Received: 14 October 2019
Accepted: 1 June 2020
First Online: 23 June 2020
: J.G.S. has stock options in Cvergenx and a pending patent for radiation sensitivity index (RSI). All other authors declare no competing interests.